NDC 68382-655-30 - glyburide and metformin hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68382-655
- Requested NDC
- 68382-655-30
- Package NDCs from labels
- 68382-655-06, 68382-655-16, 68382-655-01, 68382-655-05, 68382-655-10, 68382-655-30, 68382-655-77
- Manufacturer
- Zydus Pharmaceuticals (USA) Inc.
- Effective date
- 2026-06-10
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| glyburide and metformin hydrochloride - Zydus Pharmaceuticals (USA) Inc. | Zydus Pharmaceuticals (USA) Inc. | 2026-06-10 | HUMAN PRESCRIPTION DRUG LABEL |
| glyburide and metformin hydrochloride - Bryant Ranch Prepack | Bryant Ranch Prepack | 2021-12-27 | HUMAN PRESCRIPTION DRUG LABEL |
| Glyburide and Metformin Hydrochloride Tablets, USP Rx only | Preferred Pharmaceuticals Inc. | 2020-06-08 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68382-655-01 | glyburide and metformin hydrochloride | 100 in 1 BOTTLE | TABLET | 100 | 6 | |
| 68382-655-05 | glyburide and metformin hydrochloride | 500 in 1 BOTTLE | TABLET | 500 | 6 | |
| 68382-655-06 | glyburide and metformin hydrochloride | 30 in 1 BOTTLE | TABLET | 30 | 6 | |
| 68382-655-10 | glyburide and metformin hydrochloride | 1000 in 1 BOTTLE | TABLET | 1000 | 6 | |
| 68382-655-16 | glyburide and metformin hydrochloride | 90 in 1 BOTTLE | TABLET | 90 | 6 | |
| 68382-655-30 | glyburide and metformin hydrochloride | 10 in 1 BLISTER PACK | TABLET | 10 | 6 | |
| 68382-655-77 | glyburide and metformin hydrochloride | 10 in 1 CARTON | TABLET | 10 | 6 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Glyburide | GLYBURIDE | Teva Pharmaceuticals USA, Inc. | a56f100f-0f42-4188-81ab-04644b824040 | 2015-05-01 | Warnings, Adverse reactions | SX6K58TVWC |
| TiZO2 | TITANIUM DIOXIDE, ZINC OXIDE | Fallien Cosmeceuticals, LTD. | 30468afc-9616-4765-b046-12e97a0a7827 | 2010-12-20 | Warnings | 15FIX9V2JP |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.